Overview

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA